Diagnostic imaging capabilities of the Ocelot -Optical Coherence Tomography System, ex-vivo evaluation and clinical relevance by unknown
RESEARCH ARTICLE Open Access
Diagnostic imaging capabilities of the
Ocelot -Optical Coherence Tomography
System, ex-vivo evaluation and clinical
relevance
Suhail Dohad1,2*, John Shao3, Ian Cawich4, Manish Kankaria5 and Arjun Desai5
Abstract
Background: Optical coherence tomography (OCT) is a high-resolution sub-surface imaging modality using
near-infrared light to provide accurate and high contrast intra-vascular images. This enables accurate assessment of
diseased arteries before and after intravascular intervention.
This study was designed to corroborate diagnostic imaging equivalence between the Ocelot and the Dragonfly
OCT systems with regards to the intravascular features that are most important in clinical management of patients
with atherosclerotic vascular disease. These intravascular features were then corroborated in vivo during treatment
of peripheral arterial disease (PAD) pathology using the Ocelot catheter.
Methods: In order to compare the diagnostic information obtained by Ocelot (Avinger Inc., Redwood City, CA) and
Dragonfly (St. Jude Medical, Minneapolis, MN) OCT systems, we utilized ex-vivo preparations of arterial segments.
Ocelot and Dragonfly catheters were inserted into identical cadaveric femoral peripheral arteries for image
acquisition and interpretation.
Three independent physician interpreters assessed the images to establish accuracy and sensitivity of the diagnostic
information. Histologic evaluation of the corresponding arterial segments provided the gold standard for image
interpretation.
In vivo clinical images were obtained during therapeutic interventions that included crossing of peripheral chronic
total occlusions (CTOs) using the Ocelot catheter.
Results: Strong concordance was demonstrated when matching image characteristics between both OCT systems
and histology. The Dragonfly and Ocelot system’s vessel features were interpreted with high sensitivity (91.1–100 %)
and specificity (86.7–100 %). Inter-observer concordance was documented with excellent correlation across all
vessel features. The clinical benefit that the Ocelot OCT system provided was demonstrated by comparable
procedural images acquired at the point of therapy.
Conclusions: The study demonstrates equivalence of image acquisition and consistent physician interpretation of
images acquired by the Ocelot and the Dragonfly OCT systems in-spite of distinct image processing algorithms and
catheter configurations. This represents a dramatic shift away from both fluoroscopic imaging and diagnostic-only
OCT imaging during peripheral arterial intervention towards therapeutic devices that incorporate real time
diagnostic OCT imaging. In the clinical practice, these diagnostic capabilities have translated to best-in-class safety
and efficacy for CTO crossing using the Ocelot catheter.
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Background
The ability to have accurate and catheter based intravas-
cular imaging provides interventional physicians with in-
valuable insight into the procedural vascular anatomy
[1]. Luminal angiography has long been the gold stand-
ard for visualizing the arterial lumen and is routinely
used for arterial reconstruction. Nevertheless, the struc-
tural composition of diseased arterial beds is not ad-
equately visualized by angiography [2]. Intravascular
imaging provides important structural information,
which is frequently used for diagnostic and therapeutic
decision making during the interventional procedure.
The highest resolution source for intravascular imaging,
optical coherence tomography (OCT), is a sub-surface
imaging modality using near-infrared light [3].
Physicians use OCT to evaluate, characterize and
understand intravascular anatomic features of normal
and abnormal vessels. OCT accomplishes this via emis-
sion of a light source and no additional ioninizig
radiation.
Initially, intravascular ultrasound (IVUS) provided a
solution for in-vivo arterial assessment of luminal dimen-
sions, plaque distribution and morphology, aneurysmal
disease [4, 5], vulnerable plaque with and without rupture
[6] and stent mal-apposition [7]. Based on the same phys-
ical principles of IVUS, OCT substitutes light waves for
sound waves and provides a substantial increase in reso-
lution as compared to IVUS and high definition IVUS [8].
This directly translates to a clinical benefit where micro-
scopic disease processes can be evaluated both before and
after an endovascular intervention [9]. For example, physi-
cians are able to appreciate thin-capped fibro-atheromas
[10], vascular healing following stent deployment [11, 12]
and the extent of stent mal-apposition not reliably identifi-
able using IVUS [13]. A significant amount of research
has validated OCT’s histologic equivalence and ability to
determine reference vessel diameter, minimal luminal
diameter, lesion length and composition (calcium, lipid,
thin cap, etc.) [14–16]. Accordingly, the international
working group on intravascular optical coherence tomog-
raphy (IWG-IVOCT) recently published consensus stan-
dards defining terminology for the interpretation of intra
vascular OCT (IVOCT) [17].
The objective of this study was to illustrate the diag-
nostic capabilities of the Ocelot -OCT system. In order
to validate the imaging capabilities of the Ocelot, we
performed a comparative evaluation of the Ocelot and
the Dragonfly OCT systems. The Ocelot and Dragonfly
OCT systems individually evaluated identical intravascu-
lar features that are most important in clinical manage-
ment of atherosclerotic vascular disease (as described in
details in the Material and Methods section).
While several studies [15–18] have compared inde-
pendent OCT system images with histology for technical
validation, this is the first study comparing OCT images
from two different systems to both histology and physician
interpretation. Subsequently, and to further illustrate the
diagnostic capabilities of the Ocelot -OCT system, we
present a series of representative in-vivo images, that were
acquired by the Ocelot OCT system during interventions.
These images match the features that were evaluated ex-




The Ocelot system is designed to cross chronic total oc-
clusions (CTOs) facilitated by OCT in the peripheral
vasculature. The Dragonfly System is intended for OCT
guided diagnostic imaging of the coronary arteries. Both
imaging consoles use swept-source optical coherence
tomography and obtain a radial tomograph of the artery
by acquiring individual A-lines as the optical beam is ro-
tated along the axis of the catheter inside the artery.
Table 1 outlines the comparison for the basic operational
features of the Ocelot and the Dragonfly devices. The
two systems differ with regards to the A-line acquisition
modes, the positioning of the optical fiber on the cath-
eter, the catheter rotation speed, the optical fiber rota-
tion speed, and the modes of OCT image display.
Tissue preparation
In order to compare the diagnostic information obtained
by the Ocelot and Dragonfly OCT systems we utilized
human cadaveric vessels: the arterial segments were ex-
cised from the superficial femoral artery to the peroneal
and sectioned into individually labeled segments (Fig. 1).
In order to eliminate the need for blood dispersion
and enable the ex-vivo arterial imaging, the cadaveric ar-
terial segments were held fixed in saline bath solutions.




Dragonfly system Ocelot system
Laser Swept Source Swept Source
Domain Frequency Frequency
Interferometer Differential Path Common Path
Imaging Speed 100 Hz 1.0 Hz
Laser Scan Rate 50,000 axial lines/s 20,000 axial lines/s
Sensitivity >90 dB >90 dB
Dynamic Range >50 dB >50 dB
Imaging Range ≤5 mm ≤3.3 mm
Resolution <20 μm (axial) 25-60 μm
(lateral)
<20 μm (axial) < 300 μm
(lateral)
Tissue Penetration 1–2 mm 1–2 mm
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The cadaveric arteries were procured from: Science
Care, 21210 N19th Ave. Phoenix, AZ 85027. All donors
(or their next of kin) consented in writing, and all the
written consents are on file with Science Care.
The donor procurement was in compliment with the
Declaration of Helsinki and the local research ethics
committee: Medical Affairs at Avinger, approved the do-
nation protocol as well as the study utilization.
Device tissue imaging
Both the Ocelot and Dragonfly catheters were inserted
into identical vessel segments for image acquisition and
comparison. The image acquisition was performed ac-
cording to standard operational procedures respective
for each device. The cadaveric vessel segment subsets
that were used for comparative image analysis were
chosen based on screening for the following features
(further described in Table 2): intact vessel-wall architec-
ture of intima, media and adventitia in a single segment
(defined as Layered Structure, Table 2) well preserved
external elastic lamina (EEL), arterial segment with bi-
furcation, dissection, stent, or demonstrating arterial dis-
ease, including calcium, fibrin, lipid, thrombus, or a
combination thereof. Table 2 also outlines the nomen-
clature that was used to standardize the OCT imaging
evaluation. Accordingly, a total of 52 image sets (from
n = 9 donors and 36 vessels) were selected and OCT
images were acquired with the Ocelot and Dragonfly
catheters. Figs. 2, 3, 4, 5 and 6 depict a representative
images obtained with the Ocelot OCT system (Left
panel -A), images obtained with the Dragonfly OCT
system (Middle panel -B), and the matching histology
slides (Right panel -C). Figure 2 shows representative
images of the following features: Layered Structures
(LS), e.g. the vessel-wall architecture of intima, media and
adventitia (LS, Fig. 2), arterial Bifurcation or arterial
Branch (b, Fig. 2) and the External Elastic Lamina (EEL,
Fig. 2). Concordantly, Fig. 3 shows representative OCT
image of an arterial dissection as captured by the Ocelot
OCT system (Fig. 3, left panel -a), by the Dragonfly OCT
system (Fig. 3, middle panel -b) and the matching hist-
ology slide (Fig. 3, right panel -c). Figure 4 shows repre-
sentative imaging of a stented artery segment as captured
by Ocelot (Fig. 4, left panel -a), or by Dragonfly OCT
(Fig. 4, middle panel -b) systems. The matching histo-
logical slide (Fig. 4, right panel -c) shows representative
slide of a stented arterial segment, notice the histological
processing necessitated the removal of the metallic stent
from the fixed artery. Figure 5 shows representative image
of calcification in the arterial segment as captured by the
Ocelot OCT system (Fig. 5, left panel -a), by the Dragonfly
OCT system (Fig. 5, middle panel -b) and the matching
histology slide (Fig. 5, right panel -c). Representative ath-
erosclerotic plaque in the arterial segment is shown in
Fig. 6. The boundary of the fibrous cap encapsulating the
necrotic core and the distortion of the normal vessel-wall
architecture are apparent from the representative histo-
logical slide (Fig. 6, left panel –c).
Fig. 1 Human cadaveric vessel segments that were utilized to
compare the diagnostic information obtained by the Ocelot and
Dragonfly OCT systems
Table 2 Nomenclature for OCT evaluated features
Nomenclature Description
Layered Structure (LS) Layered structure images define the presence of the normal vessel wall architecture of intima, media and adventitia,
which is characterized by a layered architecture varying in contrast to each other and may appear as (1) a thin bright
signal intima (not always discernible), (2) a dark signal media, and (3) a bright and heterogeneous signal adventitia is
a sample image set showing layered structure.
Bifurcation (B) The point at which one arterial lumen communicates with a separate arterial lumen, which is characterized as a
luminal space with contiguous borders between communicating lumens is a sample image set showing bifurcation.
Dissection (D) A disruption of the vessel wall classified as any or all of the following: intima, media, adventitia, intramural hematoma
or intra-stent and characterized by (1) the presence of a false lumen and/or (2) identification of a tissue flap.
Stent The presence of an implanted material in the vessel structure, which is characterized by a distinct line followed by an
absence of imaging of deeper vessel structures
Non-Layered Structure (NLS) The presence of disease in the vessel structure, which is characterized by (1) a loss of a layered structure and/or (2)
localized thickening of a layer. This may include calcium, fibrin, lipid, thrombus, or a combination thereof.
External Elastic Lamina (EEL) The presence of the border between the media and adventitia, which is characterized as a contrasting border between
the two outermost layers of the vessel structure.
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Representative images of these features are shown re-
spectively, as captured by the Ocelot OCT imaging sys-
tem (Fig. 6, left panel-a) or the Dragonfly OCT system
(Fig. 6, middle panel-b).
Figures 7 and 8 demonstrate how physician inter-
preters were presented the image and answer options for
a matched image set. These images appeared independ-
ently and were randomly ordered within the full test
cohort.
Study design
The cadaveric study was designed to evaluate the con-
cordance between the Ocelot and the Dragonfly OCT
systems.
Three independent physician interpreters with signifi-
cant experience using both Dragonfly and Ocelot OCT
systems (Table 3) evaluated the images for the presence
of each feature, based on their clinical understanding of
OCT and the published literature [15, 18].
In order to prevent any bias and or comparison
amongst image sets, all images were presented in a ran-
dom fashion within each system, meaning the image sets
were not shown together. Each physician interpreter was
blinded to a unique sequence of the images. During the
physicians review process, an electronic survey (Survey
Gizmo, Boulder, CO, USA) captured all answer sets.
The clinical images were obtained during therapeutic
interventions that included CTO crossing using the
Ocelot catheter. The diagnostic information was ob-
tained after an informed consent.
Histological analysis
Third party histologic evaluation (Pathology Research
Laboratories, South San Francisco, CA) was performed
using core lab standard rating scales.
Statistical analysis
Statistical boundaries for image comparison were set in
concordance with diagnostic imaging standards. Tolerat-
ing a less than or equal to −20.0 % difference in sensitiv-
ity (positive features identification) or specificity (false
positive features identification) for imaging performance
between Ocelot and Dragonfly was deemed acceptable
for an individual arterial feature. The composite across
all arterial features was tightened to less than or
equal to −15.0 % to match OCT vessel features with
verified histology, establishing a minimum of 85 % ac-
curacy for both Ocelot and Dragonfly.
Sample size determination was based on the binomial
distribution of one-sided 95 % lower confidence bound-
ary for the sensitivity difference between Ocelot and
Dragonfly with a minimum number of matched sets
Fig. 2 Arterial segments, ex-vivo, depicting Layered Structure (LS), Bifurcation (B), and External Elastic Lamina (EEL) as seen in Ocelot (left),
Dragonfly (center) and histology (right)
Fig. 3 Ex-vivo segment with Dissection (D) seen in Ocelot (left), Dragonfly (center) and histology (right)
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providing a high probability (80 %) of success with a spe-
cified assessment compared to histology.
The calculated lower bound required a minimum of
15 matched image sets, one Ocelot and one Dragonfly
fly image, per arterial feature. A total sample size of 52-
matched image sets was used to meet the requisite indi-
vidual and composite feature requirements or analysis.
Following blinded physician analysis, kappa statistics
were calculated to determine the significance of inter-
observer variability across arterial feature identification.
Results and Discussion
The three independent physician interpreters demon-
strated strong concordance when matching image char-
acteristics between both OCT systems and histology.
Table 3 highlights the three-way analysis used to categorize
physician interpretation of images where a vessel feature is
or is not present in the 1) Ocelot image, 2) Dragonfly
image, and 3) Histologic sample. The interpretation of
each vessel feature was independently analyzed across all
images reviewed.
Across the six image components tested, the layered
structures (intima, media, and adventitia), the stent
struts and the arterial bifurcation had the lowest levels
of discordance measured amongst physician interpreters.
These three individual components were interpreted
with a 0.0 % difference between Dragonfly and Ocelot.
This correlation is consistent with the “high” level of
evidence describing these three morphologies in the
international working group for intravascular OCT
(IWG-IVOCT) consensus standards [17].
Non-layered structures (atheromatous disease) and ex-
ternal elastic lamina (EEL) had 1.1 % and 1.0 % levels of
discordance respectively. While atheromatous disease
and its components (fibrous, fibro calcific, necrotic core,
etc.) are represented by high levels of evidence in the
IWG-IVOCT consensus standards, deep wall borders of
the artery and EEL are less well defined. Regardless, the
matched sensitivity of these comparative images is suf-
ficiently high to determine diagnostic interpretative
equivalence.
In addition to individual vessel feature identification, a
kappa statistic was calculated to determine the inter-
observer agreement (Table 4). Kappa values measured
above 0.8 are considered statistically strong correlates
[19]. There was a significant consistency observed be-
tween all physician interpreters with kappa values ran-
ging from 0.82 to 1.0 across all vessel features and
between the two OCT platforms.
In Summary, the Dragonfly and Ocelot OCT system’s
vessel features were interpreted with an overall high sensi-
tivity (91.1–100 %) and specificity (86.7–100 %). There
were no differences in sensitivity between Ocelot and
Dragonfly by physician of more than 7.4 %; and similarly,
Fig. 4 Stented cadaveric arterial segment, Non-Layered Structure (NLS) and External Elastic Lamina (EEL) as seen in Dragonfly (left), Ocelot (center)
and histology (right) images
Fig. 5 Ex-vivo segment with Non Layered Structures (Calcification)
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Fig. 6 Ex-vivo segment with Non Layered Structures (Necrotic Core with Fibrous Cap)
Fig. 7 Sample Test Question (Ocelot)
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there were no differences in specificity between Ocelot
and Dragonfly of more than 10 %. These endpoint values
are consistent with diagnostic equivalence, falling well
below the statistical upper limit of −20 % sensitivity
and −15 % specificity difference level.
The matched sensitivities and specificities suggest that
both OCT systems accurately characterize the true hist-
ology of peripheral arterial disease. Additionally, the high
level of concordance demonstrates consistent clinical
interpretations of the images. The improved resolution
of OCT when compared with IVUS may explain the
Fig. 8 Sample Test Question (Dragonfly)
Table 3 Independent Physician Interpreter OCT Experience













Layered Structures Ocelot 96.3 93.3 0.90
Dragonfly 96.3 92.0 0.88
Non-Layered
Structures
Ocelot 97.8 92.1 0.91
Dragonfly 96.8 96.8 0.93
Bifurcation Ocelot 100.0 100.0 1.0
Dragonfly 100.0 100.0 1.0
Dissection Ocelot 91.0 100.0 0.93
Dragonfly 93.3 100.0 0.95
EEL Ocelot 95.8 93.3 0.89
Dragonfly 94.8 86.7 0.82
Stent Ocelot 100.0 100.0 1.0
Dragonfly 100.0 100.0 1.0
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consistent and accurate image interpretation between
physicians and across all vessel features.
With diagnostic equivalence to Dragonfly (current
FDA approved OCT imaging modality), interventional
physicians can reliably use real time Ocelot images to
understand vascular structures while guiding therapeutic
intervention across arterial chronic total occlusions [19].
This is inherently different from stand-alone diagnostic
OCT catheters, like Dragonfly, which are limited to im-
aging only without any simultaneous therapeutic appli-
cations. The ability for one catheter to combine both
diagnostic OCT with therapeutic OCT guidance may
provide several benefits to physicians and patients.
These benefits include increased clinical safety and effi-
cacy, procedural time reduction (see while treating in-
stead of see then treat), reduced healthcare consumption
(two devices in one), and reduced radiation exposure.
Figures 9, 10 and 11 demonstrate the direct clinical
benefit provided by including diagnostic imaging at the
point of therapy in the Ocelot platform technology. Pro-
cedural images acquired by the Ocelot OCT system dur-
ing clinical interventions as well as their respective
procedural angiographic images (Figs. 9 and 10) high-
light how the diagnostic OCT image provided direct
therapeutic guidance not available with conventional
angiography or stand alone diagnostic OCT.
Fig. 9 Arterial branch (annotated by the dashed arrow) detected by the Ocelot OCT catheter in the course of CTO recanalization (panel a) and
the corresponding angiographic image (panel b). The strait arrow indicates chronic occlusion due to a fibrotic plaque
Fig. 10 In stent restenosis depicted by the Ocelot OCT catheter in the course of CTO recanalization (panel a) and the corresponding angiographic
image (panel b). The strait arrow annotates the stent struts, and the dashed arrow annotates the occlusive neo-intimal tissue
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Figure 9 demonstrates an arterial branch as depicted
by the Ocelot OCT catheter and the corresponding
angiographic image. The OCT guidance that Ocelot pro-
vided during this intervention enabled clear intravascu-
lar visualization of the bifurcating branch during the
CTO crossing, eliminating unnecessary collateral track-
ing or potential injury.
Figure 10 shows detection of stent struts in the oc-
cluded in-stent restenosis artery and the corresponding
angiographic image. OCT guidance enabled intra-stent
crossing with real-time confirmation of catheter posi-
tioning. Figure 11 depicts additional arterial features that
were detected by the Ocelot OCT system and impacted
the subsequent therapeutic algorithms; A. thrombotic
burden in the occluded artery, B. calcium nodules em-
bedded in the adventitia, and C. calcium aggregates in
the medial arterial layer.
Future applications combining real time OCT guid-
ance during therapeutic intervention may further serve
to improve outcomes and procedural efficiencies when
treating both peripheral and coronary arterial disease.
Such technologies may include OCT guided directional
atherectomy, true lumen re-entry, stent deployment sys-
tems, and local drug delivery mechanisms.
Limitations of this study include comparative testing
within an ex-vivo in (bloodless) environment and phys-
ician image interpretation using single frame images, as
opposed to live OCT files. Additionally, future studies
should consider including intra-observer variance meas-
urement. As a result of strong inter-rater agreement
measured in this study, intra-rater assessment was not
pursued.
Conclusions
The comparison of Ocelot and Dragonfly via the cadav-
erous model successfully validated comparable identifi-
cation the most pertinent vascular anatomies and
pathologies, encountered during peripheral arterial in-
terventions, including bifurcations, calcium or arterial
dissections.
Accordingly, the diagnostic capabilities of the Ocelot
OCT system demonstrated in this paper have been suc-
cessfully translated into clinical best-in-class safety (98 %)
and efficacy (97 %) for peripheral CTO crossing as dem-
onstrated by the pivotal CONNECT II trial [19].
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